• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素在6-羟基多巴胺诱导的帕金森病大鼠模型中减轻运动症状的剂量。

The dosage of curcumin to alleviate movement symptoms in a 6-hydroxydopamine-induced Parkinson's disease rat model.

作者信息

Liu Xiaoyu, Zhang Hao, Li Chuanfen, Chen Zhibin, Gao Qian, Han Muxuan, Zhao Feng, Chen Dan, Chen Qiuyue, Hu Minghui, Li Zifa, Wei Sheng, Geng Xiwen

机构信息

Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, China.

Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.

出版信息

Heliyon. 2023 Jun 7;9(6):e16921. doi: 10.1016/j.heliyon.2023.e16921. eCollection 2023 Jun.

DOI:10.1016/j.heliyon.2023.e16921
PMID:37484231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10360947/
Abstract

BACKGROUND

Curcumin is a natural compound with extensive pharmacological effects. This research is to verify the optimal dose and administration duration efficacy of curcumin in alleviating the movement symptoms of Parkinson's disease (PD).

METHODS

Wistar rats were divided into six groups including control, model, levodopa treatment and low/middle/high (40/80/160 mg/kg/d) curcumin treatment groups. After stereotactic brain injection of 6-hydroxydopamine (6-OHDA), curcumin was given by intragastric administration for 2 weeks. To evaluate the drug effect, the rats received behavioral tests including apomorphine (APO)-induced rotation test, rotarod test and open field test. Then the rats were sacrificed and the brain slices including substantia nigra pars compacta (SNc) were used for immunofluorescence staining.

RESULTS

After 6-OHDA injection, the model group showed typical movement symptoms including the severe APO-induced rotation to the healthy side, decreased latency in the rotarod with constant or accelerative mode, and decreased total distance and average speed in the open field test. In the results of immunofluorescence staining, the 6-OHDA induced a severe damage of dopaminergic neurons in SNc. The 160 mg/kg/d treatment of curcumin to intervene for 2 weeks alleviated most of the behavioral disorders but the 40/80 mg/kg/d treatment showed limitations. Then, we compared the effect of 1 week intervention to the 2 weeks with 160 mg/kg/d treatment of curcumin to intervene and results indicated that the treatment of 2 weeks could better alleviate the symptoms.

CONCLUSIONS

Curcumin alleviated 6-OHDA-induced movement symptoms in a PD rat model. Additionally, the effect of curcumin against PD indicated dose and duration dependent and the intervention of 160 mg/kg/d for 2 weeks showed optimally therapeutic effect.

摘要

背景

姜黄素是一种具有广泛药理作用的天然化合物。本研究旨在验证姜黄素缓解帕金森病(PD)运动症状的最佳剂量和给药持续时间疗效。

方法

将Wistar大鼠分为六组,包括对照组、模型组、左旋多巴治疗组和低/中/高(40/80/160mg/kg/d)姜黄素治疗组。在立体定向脑内注射6-羟基多巴胺(6-OHDA)后,通过灌胃给予姜黄素2周。为评估药物效果,大鼠接受行为测试,包括阿扑吗啡(APO)诱导的旋转试验、转棒试验和旷场试验。然后处死大鼠,取包括黑质致密部(SNc)的脑片进行免疫荧光染色。

结果

注射6-OHDA后,模型组出现典型的运动症状,包括APO诱导的向健康侧严重旋转、转棒试验中恒定或加速模式下潜伏期缩短以及旷场试验中总距离和平均速度降低。在免疫荧光染色结果中,6-OHDA导致SNc中多巴胺能神经元严重损伤。160mg/kg/d的姜黄素治疗干预2周可缓解大部分行为障碍,但40/80mg/kg/d的治疗显示出局限性。然后,我们比较了160mg/kg/d的姜黄素治疗干预1周和2周的效果,结果表明2周治疗能更好地缓解症状。

结论

姜黄素可缓解PD大鼠模型中6-OHDA诱导的运动症状。此外,姜黄素对PD的作用呈剂量和时间依赖性,160mg/kg/d干预2周显示出最佳治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b75/10360947/a3b4ba2b3535/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b75/10360947/a3b4ba2b3535/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b75/10360947/a3b4ba2b3535/gr1.jpg

相似文献

1
The dosage of curcumin to alleviate movement symptoms in a 6-hydroxydopamine-induced Parkinson's disease rat model.姜黄素在6-羟基多巴胺诱导的帕金森病大鼠模型中减轻运动症状的剂量。
Heliyon. 2023 Jun 7;9(6):e16921. doi: 10.1016/j.heliyon.2023.e16921. eCollection 2023 Jun.
2
Study on Effect of Striatal mGluR2/3 in Alleviating Motor Dysfunction in Rat PD Model Treated by Exercise Therapy.纹状体代谢型谷氨酸受体2/3在运动疗法治疗大鼠帕金森病模型中缓解运动功能障碍的作用研究
Front Aging Neurosci. 2019 Oct 2;11:255. doi: 10.3389/fnagi.2019.00255. eCollection 2019.
3
Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.硫化氢在急性6-羟基多巴胺诱导的帕金森病动物模型中的抗帕金森病及神经保护作用评估:行为学、组织学和生物化学研究
Neurol Res. 2018 Jul;40(7):523-531. doi: 10.1080/01616412.2017.1390903. Epub 2018 May 4.
4
Protective effect of curcumin against rotenone-induced substantia nigra pars compacta neuronal dysfunction.姜黄素对鱼藤酮诱导的黑质致密部神经元功能障碍的保护作用。
Metab Brain Dis. 2022 Apr;37(4):1111-1118. doi: 10.1007/s11011-022-00941-6. Epub 2022 Mar 3.
5
6-Hydroxydopamine-Induced Neurotoxicity in Rat Model of Parkinson's Disease: Is Reversed via Anti-Oxidative Activities of Curcumin and Aerobic Exercise Therapy.姜黄素与有氧运动疗法通过抗氧化活性逆转帕金森病大鼠模型的 6-羟多巴胺诱导的神经毒性
Physiol Res. 2022 Aug 31;71(4):551-560. doi: 10.33549/physiolres.934929.
6
L-DOPA-elicited abnormal involuntary movements in the rats damaged severely in substantia nigra by 6-hydroxydopamine.6-羟多巴胺损毁黑质的大鼠给予 L-DOPA 后诱发异常不自主运动。
Ann Palliat Med. 2020 May;9(3):947-956. doi: 10.21037/apm.2020.03.32. Epub 2020 Apr 7.
7
The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.抗衰老蛋白 klotho 减轻帕金森病 6-羟多巴胺大鼠模型黑质纹状体多巴胺能通路损伤:涉及蛋白激酶 A/钙调蛋白依赖性蛋白激酶 II/环磷酸腺苷反应元件结合蛋白信号通路。
Exp Gerontol. 2017 Dec 15;100:70-76. doi: 10.1016/j.exger.2017.10.023. Epub 2017 Nov 5.
8
Comparison between Tail Suspension Swing Test and Standard Rotation Test in Revealing Early Motor Behavioral Changes and Neurodegeneration in 6-OHDA Hemiparkinsonian Rats.悬尾摆动试验与标准旋转试验在揭示 6-OHDA 半帕金森病大鼠早期运动行为改变和神经退行性变中的比较。
Int J Mol Sci. 2020 Apr 20;21(8):2874. doi: 10.3390/ijms21082874.
9
Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.多巴胺受体激动剂R-阿扑吗啡对帕金森病部分损伤大鼠模型的慢性全身治疗效果:黑质多巴胺能神经元的电生理学研究
Chin J Physiol. 2011 Apr 30;54(2):96-104. doi: 10.4077/cjp.2011.amm014.
10
Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease.姜黄素通过螯合铁保护帕金森病 6-羟多巴胺大鼠模型中的黑质多巴胺能神经元。
Neurosci Bull. 2012 Jun;28(3):253-8. doi: 10.1007/s12264-012-1238-2.

引用本文的文献

1
Curcumin treatment reduces motor impairments and protects against rotenone-induced neurodegeneration in a rat model of Parkinson disease.姜黄素治疗可减轻帕金森病大鼠模型的运动障碍,并预防鱼藤酮诱导的神经退行性变。
Metab Brain Dis. 2025 Sep 15;40(7):267. doi: 10.1007/s11011-025-01698-4.
2
The Neuroprotective Role of Curcumin: From Molecular Pathways to Clinical Translation-A Narrative Review.姜黄素的神经保护作用:从分子途径到临床转化——一篇叙述性综述
Nutrients. 2025 Sep 6;17(17):2884. doi: 10.3390/nu17172884.
3
Nootropic foods in neurodegenerative diseases: mechanisms, challenges, and future.

本文引用的文献

1
Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: A pilot randomized, triple-blind, placebo-controlled trial.姜黄素作为帕金森病附加治疗的评价:一项先导随机、三盲、安慰剂对照试验。
Clin Neurol Neurosurg. 2022 Jul;218:107300. doi: 10.1016/j.clineuro.2022.107300. Epub 2022 May 18.
2
Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson's models.姜黄素通过诱导自噬对 6-羟多巴胺帕金森模型的神经保护作用。
Neurochem Int. 2022 May;155:105297. doi: 10.1016/j.neuint.2022.105297. Epub 2022 Feb 2.
3
Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
神经退行性疾病中的益智食物:作用机制、挑战与未来
Transl Neurodegener. 2025 Apr 3;14(1):17. doi: 10.1186/s40035-025-00476-7.
4
The Dynamic Role of Curcumin in Mitigating Human Illnesses: Recent Advances in Therapeutic Applications.姜黄素在减轻人类疾病中的动态作用:治疗应用的最新进展
Pharmaceuticals (Basel). 2024 Dec 11;17(12):1674. doi: 10.3390/ph17121674.
DL-3-正丁基苯酞通过抑制 NLRP3 炎性小体和改善线粒体损伤来拯救帕金森病模型中的多巴胺能神经元。
Front Immunol. 2021 Dec 1;12:794770. doi: 10.3389/fimmu.2021.794770. eCollection 2021.
4
The 6-hydroxydopamine Rat Model of Parkinson's Disease.6-羟多巴胺帕金森病大鼠模型。
J Vis Exp. 2021 Oct 27(176). doi: 10.3791/62923.
5
Neuroprotective Activities of Curcumin in Parkinson's Disease: A Review of the Literature.姜黄素在帕金森病中的神经保护作用:文献综述。
Int J Mol Sci. 2021 Oct 18;22(20):11248. doi: 10.3390/ijms222011248.
6
Movement of prion-like α-synuclein along the gut-brain axis in Parkinson's disease: A potential target of curcumin treatment.帕金森病中朊病毒样α-突触核蛋白沿肠脑轴的运动:姜黄素治疗的一个潜在靶点。
Eur J Neurosci. 2021 Jul;54(2):4695-4711. doi: 10.1111/ejn.15324. Epub 2021 Jun 23.
7
Parkinsonism-like Disease Induced by Rotenone in Rats: Treatment Role of Curcumin, Dopamine Agonist and Adenosine A Receptor Antagonist.鱼藤酮诱导大鼠帕金森样疾病:姜黄素、多巴胺激动剂和腺苷 A 受体拮抗剂的治疗作用。
Curr Aging Sci. 2022 Feb 3;15(1):65-76. doi: 10.2174/1874609814666210526115740.
8
Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction.帕金森病的非运动症状:早期精神和认知功能障碍的神经生物学。
Neuroscientist. 2023 Feb;29(1):97-116. doi: 10.1177/10738584211011979. Epub 2021 May 8.
9
Levodopa affects spike and local field synchronisation in the pedunculopontine nucleus of a rat model of Parkinson's disease.左旋多巴影响帕金森病大鼠模型脑桥被盖核的棘波和局部场同步。
Aging (Albany NY). 2021 Feb 26;13(5):7314-7329. doi: 10.18632/aging.202585.
10
Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats.褪黑素对 6-OHDA 损伤大鼠运动和记忆障碍的有益作用。
J Mol Neurosci. 2021 Apr;71(4):702-712. doi: 10.1007/s12031-020-01760-z. Epub 2021 Jan 5.